Prestige Biologics Co., Ltd.

₩1,197As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:334970Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (35.38%)
Div yield —
ROE (45.40%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.50
PE TTM —
TSR TTM (60.30%)
Mkt cap ₩93.07B
ROIC (14.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,528
27.69%
(85.13%)
Hold 1|4|5|6|5
2Q26
3Q26
4Q26
1Q27
Earnings per share₩
12.72
13.10
14.65
16.12
15.43%
11.37%
19.31%
38.11%
Revenue₩B
4.404
4.296
4.540
4.612
11.34%
5.78%
10.63%
10.60%
Peers (US$68.62M)
Cap (US$)
PE
83.39M
—
77.51M
—
73.82M
5.962x
Capital
TTM
5Y
10Y
Leveragex
0.318
(0.060)
(0.054)
EBIT/Intx
1.105
0.432
0.471
Own earn%
166.23
68.96
75.86
Sh yield%
49.22
51.67
52.04
Owners
Insiders/Inst%
6.77
89.51
Short interest%
3.49
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
7